ProfileGDS4718 / 204841_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 40% 39% 43% 43% 61% 57% 45% 42% 47% 49% 42% 48% 52% 52% 54% 47% 46% 39% 30% 41% 48% 47% 47% 50% 49% 46% 33% 43% 49% 52% 60% 42% 58% 40% 50% 46% 41% 38% 41% 51% 45% 43% 47% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9154138
GSM549102patient 115, normal, homogenized [OPG study]5.0171640
GSM549104patient 119, normal, homogenized [OPG study]4.9128939
GSM549108patient 138, normal, homogenized [OPG study]5.2046243
GSM549119patient 077, normal, homogenized [OPG study]5.1264343
GSM549133patient 032, cancer, homogenized [OPG study]6.1824261
GSM549139patient 042, cancer, homogenized [OPG study]5.9202257
GSM549099patient 107, normal, homogenized [OPG study]5.2525145
GSM549109patient 139, normal, homogenized [OPG study]5.0921842
GSM549110patient 046, normal, homogenized [OPG study]5.3513447
GSM549114patient 063, normal, homogenized [OPG study]5.4202949
GSM549122patient 082, normal, homogenized [OPG study]5.1058442
GSM549134patient 033, cancer, homogenized [OPG study]5.3774748
GSM549136patient 036, cancer, homogenized [OPG study]5.580652
GSM549140patient 044, cancer, homogenized [OPG study]5.5998952
GSM549111patient 047, normal, homogenized [OPG study]5.7283154
GSM549113patient 057, normal, homogenized [OPG study]5.3144747
GSM549132patient 031, cancer, homogenized [OPG study]5.2743446
GSM549137patient 038, cancer, homogenized [OPG study]4.9205739
GSM549142patient 047, cancer, homogenized [OPG study]4.6377930
GSM549100patient 110, normal, homogenized [OPG study]5.0469441
GSM549107patient 135, normal, homogenized [OPG study]5.3605548
GSM549115patient 068, normal, homogenized [OPG study]5.2866147
GSM549116patient 072, normal, homogenized [OPG study]5.3129347
GSM549120patient 078, normal, homogenized [OPG study]5.4875950
GSM549131patient 030, cancer, homogenized [OPG study]5.390649
GSM549118patient 074, normal, homogenized [OPG study]5.2654946
GSM549129patient 027, cancer, homogenized [OPG study]4.6988933
GSM549123patient 088, normal, homogenized [OPG study]5.1331643
GSM549124patient 006, cancer, homogenized [OPG study]5.5061449
GSM549126patient 015, cancer, homogenized [OPG study]5.6076852
GSM549128patient 025, cancer, homogenized [OPG study]6.1497360
GSM549103patient 117, normal, homogenized [OPG study]5.1593242
GSM549117patient 073, normal, homogenized [OPG study]5.9346258
GSM549138patient 041, cancer, homogenized [OPG study]4.9987540
GSM549141patient 045, cancer, homogenized [OPG study]5.4684850
GSM549130patient 028, cancer, homogenized [OPG study]5.3095346
GSM549101patient 111, normal, homogenized [OPG study]5.0524641
GSM549105patient 128, normal, homogenized [OPG study]4.9112238
GSM549106patient 134, normal, homogenized [OPG study]5.0151141
GSM549112patient 048, normal, homogenized [OPG study]5.5855451
GSM549125patient 011, cancer, homogenized [OPG study]5.2502245
GSM549127patient 024, cancer, homogenized [OPG study]5.1159643
GSM549135patient 035, cancer, homogenized [OPG study]5.3350547